Quantification of hepatic UDP glucuronosyltransferase 1A splice variant expression and correlation of udp glucuronosyltransferase 1A1 variant expression with glucuronidation activity

Journal of Pharmacology and Experimental Therapeutics

Volumn 342, Issue 3, 2012, Pages 720-729

  Jones, Nathan R ^a   Sun, Dongxiao ^a   Freeman, Willard M ^a   Lazarus, Philip ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCURONOSYLTRANSFERASE 1A1; GLUCURONOSYLTRANSFERASE 1A4; GLUCURONOSYLTRANSFERASE 1A6; GLUCURONOSYLTRANSFERASE 1A9; MESSENGER RNA; RALOXIFENE; SMALL INTERFERING RNA;

ALLELE; ARTICLE; CELL STRAIN HEPG2; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG GLUCURONIDATION; ENZYME ACTIVITY; EXON; GENE EXPRESSION; GENE SILENCING; GENETIC VARIABILITY; HOMOZYGOTE; HUMAN; HUMAN TISSUE; MICROSOME; PRIORITY JOURNAL; UGT 1A GENE; UGT 1A1 GENE; WILD TYPE;

ALTERNATIVE SPLICING; CELL LINE; CELL LINE, TUMOR; EXONS; GENE KNOCKDOWN TECHNIQUES; GLUCURONOSYLTRANSFERASE; HEP G2 CELLS; HUMANS; LIVER; MICROSOMES, LIVER; RALOXIFENE; RNA, MESSENGER; RNA, SMALL INTERFERING;

EID: 84865185090     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.112.192658     Document Type: Article

References (49)

1. Amit M, Sela N, Keren H, Melamed Z, Muler I, Shomron N, Izraeli S, and Ast G (2007) Biased exonization of transposed elements in duplicated genes: A lesson from the TIF-IA gene. BMC Mol Biol 8:109.
2. tk;2Ando Y, Saka H, Asai G, Sugiura S, Shimokata K, and Kamataki T (1998) UGT1A1 genotypes and glucuronidation of SN-38, the active metabolite of irinotecan. Ann Oncol 9:845-847.
3. Beaulieu M, Lévesque E, Hum DW, and Bélanger A (1998) Isolation and characterization of a human orphan UDP-glucuronosyltransferase, UGT2B11. Biochem Biophys Res Commun 248:44-50. (Pubitemid 28418184)
4. Bellemare J, Rouleau M, Girard H, Harvey M, and Guillemette C (2010a) Alternatively spliced products of the UGT1A gene interact with the enzymatically active proteins to inhibit glucuronosyltransferase activity in vitro. Drug Metab Dispos 38:1785-1789.
5. Bellemare J, Rouleau M, Harvey M, and Guillemette C (2010b) Modulation of the human glucuronosyltransferase UGT1A pathway by splice isoform polypeptides is mediated through protein-protein interactions. J Biol Chem 285:3600-3607.
6. Bellemare J, Rouleau M, Harvey M, Popa I, Pelletier G, Têtu B, and Guillemette C (2011) Immunohistochemical expression of conjugating UGT1A-derived isoforms in normal and tumoral drug-metabolizing tissues in humans. J Pathol 223:425-435.
7. Bellemare J, Rouleau M, Harvey M, Têtu B, and Guillemette C (2010c) Alternative-splicing forms of the major phase II conjugating UGT1A gene negatively regulate glucuronidation in human carcinoma cell lines. Pharmacogenomics J 10:431-441.
8. Benoit-Biancamano MO, Connelly J, Villeneuve L, Caron P, and Guillemette C (2009) Deferiprone glucuronidation by human tissues and recombinant UDP glucuronosyltransferase 1A6: an in vitro investigation of genetic and splice variants. Drug Metab Dispos 37:322-329.
9. Beutler E, Gelbart T, and Demina A (1998) Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism? Proc Natl Acad Sci U S A 95:8170-8174. (Pubitemid 28326085)
10. Bosma P, Chowdhury JR, and Jansen PH (1995a) Genetic inheritance of Gilbert's syndrome. Lancet 346:314-315.
11. Bosma PJ (2003) Inherited disorders of bilirubin metabolism. J Hepatol 38:107-117.
12. Bosma PJ, Chowdhury JR, Bakker C, Gantla S, de Boer A, Oostra BA, Lindhout D, Tytgat GN, Jansen PL, and Oude Elferink RP (1995b) The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med 333:1171-1175.
13. Burchell B and Hume R (1999) Molecular genetic basis of Gilbert's syndrome. J Gastroenterol Hepatol 14:960-966. (Pubitemid 29487290)
14. Chen C, Ara T, and Gautheret D (2009) Using Alu elements as polyadenylation sites: a case of retroposon exaptation. Mol Biol Evol 26:327-334.
15. Chen LL, DeCerbo JN, and Carmichael GG (2008) Alu element-mediated gene silencing. EMBO J 27:1694-1705.
16. Coffman BL, Green MD, King CD, and Tephly TR (1995) Cloning and stable expression of a cDNA encoding a rat liver UDP-glucuronosyltransferase (UDP-glucuronosyltransferase 1.1) that catalyzes the glucuronidation of opioids and bilirubin. Mol Pharmacol 47:1101-1105.
17. Coughtrie MW, Burchell B, and Bend JR (1987) Purification and properties of rat kidney UDP-glucuronosyltransferase. Biochem Pharmacol 36:245-251. (Pubitemid 17004922)
18. Dutton GF (1980). Glucuronidation of Drugs and Other Compounds. CRC Press, Boca Raton, FL.
19. Ethell BT, Beaumont K, Rance DJ, and Burchell B (2001) Use of cloned and expressed human UDP-glucuronosyltransferases for the assessment of human drug conjugation and identification of potential drug interactions. Drug Metab Dispos 29:48-53. (Pubitemid 32041679)
20. Fang JL and Lazarus P (2004) Correlation between the UDP- glucuronosyltransferase (UGT1A1) TATAA box polymorphism and carcinogen detoxification phenotype: significantly decreased glucuronidating activity against benzo(a)pyrene-7,8-dihydrodiol(-) in liver microsomes from subjects with the UGT1A1*28 variant. Cancer Epidemiol Biomarkers Prev 13:102-109.
21. Freeman WM, Walker SJ, and Vrana KE (1999) Quantitative RT-PCR: pitfalls and potential. Biotechniques 26:112-122, 124-125.
22. Girard H, Lévesque E, Bellemare J, Journault K, Caillier B, and Guillemette C (2007) Genetic diversity at the UGT1 locus is amplified by a novel 3́ alternative splicing mechanism leading to nine additional UGT1A proteins that act as regulators of glucuronidation activity. Pharmacogenet Genomics 17:1077-1089. (Pubitemid 351339492)
23. Gong QH, Cho JW, Huang T, Potter C, Gholami N, Basu NK, Kubota S, Carvalho S, Pennington MW, Owens IS, et al. (2001) Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. Pharmacogenetics 11:357-368. (Pubitemid 32537410)
24. Guillemette C, De Vivo I, Hankinson SE, Haiman CA, Spiegelman D, Housman DE, and Hunter DJ (2001) Association of genetic polymorphisms in UGT1A1 with breast cancer and plasma hormone levels. Cancer Epidemiol Biomarkers Prev 10:711-714. (Pubitemid 32703208)
25. Guillemette C, Millikan RC, Newman B, and Housman DE (2000) Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and association with breast cancer among African Americans. Cancer Res 60:950-956. (Pubitemid 30129531)
26. Hoskins JM, Goldberg RM, Qu P, Ibrahim JG, and McLeod HL (2007) UGT1A1*28 genotype and irinotecan-induced neutropenia: dose matters. J Natl Cancer Inst 99:1290-1295. (Pubitemid 47394168)
27. Iyer L, Das S, Janisch L, Wen M, Ramírez J, Karrison T, Fleming GF, Vokes EE, Schilsky RL, and Ratain MJ (2002) UGT1A1*28 polymorphism as a determinant of irinotecan disposition and toxicity. Pharmacogenomics J 2:43-47. (Pubitemid 34982202)
28. Iyer L, Hall D, Das S, Mortell MA, Ramírez J, Kim S, Di Rienzo A, and Ratain MJ (1999) Phenotype-genotype correlation of in vitro SN-38 (active metabolite of irinotecan) and bilirubin glucuronidation in human liver tissue with UGT1A1 promoter polymorphism. Clin Pharmacol Ther 65:576-582. (Pubitemid 29237332)
29. Izukawa T, Nakajima M, Fujiwara R, Yamanaka H, Fukami T, Takamiya M, Aoki Y, Ikushiro S, Sakaki T, and Yokoi T (2009) Quantitative analysis of UDP-glucuronosyltransferase (UGT) 1A and UGT2B expression levels in human livers. Drug Metab Dispos 37:1759-1768.
30. Kim DD, Kim TT, Walsh T, Kobayashi Y, Matise TC, Buyske S, and Gabriel A (2004) Widespread RNA editing of embedded alu elements in the human transcriptome. Genome Res 14:1719-1725. (Pubitemid 39276429)
31. Kim E, Goren A, and Ast G (2008) Alternative splicing: current perspectives. BioEssays 30:38-47.
32. Lévesque E, Girard H, Journault K, Lépine J, and Guillemette C (2007) Regulation of the UGT1A1 bilirubin-conjugating pathway: role of a new splicing event at the UGT1A locus. Hepatology 45:128-138. (Pubitemid 46144372)
33. Lin L, Shen S, Tye A, Cai JJ, Jiang P, Davidson BL, and Xing YS (2008). Diverse splicing patterns of exonized Alu elements in human tissues. PLoS Genet 4:e1000225.
34. Livak KJ and Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods 25:402-408. (Pubitemid 34164012)
35. Mersch B, Sela N, Ast G, Suhai S, and Hotz-Wagenblatt A (2007) SERpredict: detection of tissue- or tumor-specific isoforms generated through exonization of transposable elements. BMC Genet 8:78.
36. Monaghan G, Ryan M, Seddon R, Hume R, and Burchell B (1996) Genetic variation in bilirubin UPD-glucuronosyltransferase gene promoter and Gilbert's syndrome. Lancet 347:578-581. (Pubitemid 26070740)
37. Nakamura A, Nakajima M, Yamanaka H, Fujiwara R, and Yokoi T (2008) Expression of UGT1A and UGT2B mRNA in human normal tissues and various cell lines. Drug Metab Dispos 36:1461-1464.
38. Nekrutenko A and Li WH (2001) Transposable elements are found in a large number of human protein-coding genes. Trends Genet 17:619-621. (Pubitemid 32973815)
39. Ohno S and Nakajin S (2009) Determination of mRNA expression of human UDP-glucuronosyltransferases and application for localization in various human tissues by real-time reverse transcriptase-polymerase chain reaction. Drug Metab Dispos 37:32-40.
40. Olson KC, Dellinger RW, Zhong Q, Sun D, Amin S, Spratt TE, and Lazarus P (2009) Functional characterization of low-prevalence missense polymorphisms in the UDP-glucuronosyltransferase 1A9 gene. Drug Metab Dispos 37:1999-2007.
41. Price AL, Eskin E, and Pevzner PA (2004) Whole-genome analysis of Alu repeat elements reveals complex evolutionary history. Genome Res 14:2245-2252. (Pubitemid 39517330)
42. Roy-Engel AM, El-Sawy M, Farooq L, Odom GL, Perepelitsa-Belancio V, Bruch H, Oyeniran OO, and Deininger PL (2005) Human retroelements may introduce intragenic polyadenylation signals. Cytogenet Genome Res 110:365-371.
43. Smalheiser NR and Torvik VI (2006) Alu elements within human mRNAs are probable microRNA targets. Trends Genet 22:532-536. (Pubitemid 44374128)
44. Sorek R, Ast G, and Graur D (2002) Alu-containing exons are alternatively spliced. Genome Res 12:1060-1067. (Pubitemid 34785198)
45. Trdan Lusin T, Trontelj J, and Mrhar A (2011) Raloxifene glucuronidation in human intestine, kidney, and liver microsomes and in human liver microsomes genotyped for the UGT1A1*28 polymorphism. Drug Metab Dispos 39:2347-2354.
46. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, and Speleman F (2002). Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3:RESEARCH0034.
47. VanGuilder HD, Vrana KE, and Freeman WM (2008) Twenty-five years of quantitative PCR for gene expression analysis. Biotechniques 44:619-626. (Pubitemid 351656280)
48. Wang ET, Sandberg R, Luo S, Khrebtukova I, Zhang L, Mayr C, Kingsmore SF, Schroth GP, and Burge CB (2008) Alternative isoform regulation in human tissue transcriptomes. Nature 456:470-476. (Pubitemid 352759009)
49. Zheng Z, Fang JL, and Lazarus P (2002) Glucuronidation: an important mechanism for detoxification of benzo[a]pyrene metabolites in aerodigestive tract tissues. Drug Metab Dispos 30:397-403. (Pubitemid 34263824)